LEVELS OF HOMOTYPIC NEUTRALIZING ANTIBODY IN HUMAN POLIOMYELITIS THREE YEARS AFTER INFECTION
Open Access
- 1 November 1952
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 96 (5), 477-490
- https://doi.org/10.1084/jem.96.5.477
Abstract
Quantitative neutralization testes in monkeys were carried out on sera obtained from 7 patients, 3 mos., and 3 yrs. after an attack of poliomyelitis. The serum specimens were tested against 100 to 1000 PD50 of the patient''s own strain of virus, recovered during the acute phase of the illness; all the strains were Type 1. The 6 patients, aged 6 mos. to 13 yrs., who had a paralytic attack of the disease, all exhibited very high levels of neutralizing antibody at 3 yrs. as well as at 3 mos. after onset. The 50% serum dilution titers ranged from about 1180 to at least 1:860. Since the max. titers were not established, it is not known to what extent, if any, the level of antibody may have dropped over the 3 yr. period. One of the patients, with a diagnosis of non-paralytic poliomyelitis, had a negligible or questionable antibody response during convalescence and no demonstrable antibody at 3 yrs.; there is justifiable doubt as to whether the Type 1 poliomyelitis virus recovered from this patient had actually caused infection. Tests for Lansing neutralizing antibody indicated that the 5 patients who had no evidence of previous infection with Type 2 poliomyelitis virus had not become infected with it during the 3-yr. period. This suggested that these patients did not live in an environment in which infection with poliomyelitis virus is frequent. It is concluded, therefore, that in human beings, paralytic infections due to Type 1 poliomyelitis virus produce large amounts of homotypic neutralizing antibody, which persists at high levels for a period of at least 3 yrs.Keywords
This publication has 9 references indexed in Scilit:
- TRANSITORY APPEARANCE OF TYPE 2 NEUTRALIZING ANTIBODY IN PATIENTS INFECTED WITH TYPE 1 POLIOMYELITIS VIRUSThe Journal of Experimental Medicine, 1952
- Paralytic Consequences of Poliomyelitis Infection in Different Parts of the World and in Different Population GroupsAmerican Journal of Public Health and the Nations Health, 1951
- ANTIBODIES TO THREE DIFFERENT ANTIGENIC TYPES OF POLIOMYELITIS VIRUS IN SERA FROM NORTH ALASKAN ESKIMOS123American Journal of Epidemiology, 1951
- EXPERIMENTAL STUDIES ON PASSIVE IMMUNIZATION AGAINST POLIOMYELITISAmerican Journal of Epidemiology, 1951
- Passive Immunity in Poliomyelitis: II Lansing Antibody Content of Human Gamma Globulins.Experimental Biology and Medicine, 1951
- AGE INCIDENCE AND SEASONAL DEVELOPMENT OF NEUTRALIZING ANTIBODIES TO LANSING POLIOMYELITIS VIRUS12American Journal of Epidemiology, 1950
- Neutralization of Three Immunological Types of Poliomyelitis Virus by Human Gamma Globulin.Experimental Biology and Medicine, 1949
- ANTIBODY RESPONSE OF PATIENTS WITH POLIOMYELITIS TO VIRUS RECOVERED FROM THEIR OWN ALIMENTARY TRACTThe Journal of Experimental Medicine, 1949
- Serum Neutralizing Antibodies to the Infecting Strain of Virus in Poliomyelitis Patients.Experimental Biology and Medicine, 1948